CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: institutional ownership and insider trading
614 funds reported holding $14.8B of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. in their latest 13F filings; in Q2 2026 funds net sold $73.4M, with 71 new positions and 64 funds selling out; over the last 12 months insiders bought $7.34K and sold $43.7M on the open market.
Famous investors holding CRL
- Izzy Englander (Millennium Management): $115M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $291M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $7.16M, 0.0% of the portfolio
Largest institutional holders of CRL
- VANGUARD GROUP INC — $1.17B
- FMR LLC — $962M
- BlackRock, Inc. (BLK) — $861M
- VANGUARD CAPITAL MANAGEMENT LLC — $714M
- Invesco Ltd. (IVZ) — $677M
- HARRIS ASSOCIATES L P — $508M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $501M
- Banque Cantonale Vaudoise — $495M
- Allspring Global Investments Holdings, LLC — $436M
- STATE STREET CORP (STT, STT-PG) — $423M
Recent CRL insider trades
- Oct 21, 2026: Parisotto Shannon M sold 2,156 shares ($743K)
- Oct 5, 2026: Parisotto Shannon M sold 981 shares ($303K)
- Sep 30, 2026: Coleman Glenn bought 10 shares ($2.97K)
- Aug 25, 2026: Foster James C sold 33,561 shares ($10.1M)
Members of Congress trading CRL
- May 15, 2025: Robert P. Bresnahan, Jr. sold $1.00K–$15.0K
- May 12, 2025: Jefferson Shreve sold $15.0K–$50.0K
- May 8, 2025: Jefferson Shreve bought $15.0K–$50.0K
- Apr 8, 2025: Robert P. Bresnahan, Jr. bought $15.0K–$50.0K
- Jan 15, 2025: Julie Johnson bought $1.00K–$15.0K
5%+ owners
- FMR LLC: 10.2% (Schedule 13G/A, filed Sep 8, 2026)
- Vanguard Capital Management: 7.4% (Schedule 13G, filed Apr 29, 2026)
- Invesco Ltd.: 6.2% (Schedule 13G, filed Aug 13, 2026)